To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: Immunex Receives FDA Clearance for Etoposide Chemotherapy Agent URL: http://www.pslgroup.com/dg/6A5A.htm Doctor's Guide March 15, 1996
SEATTLE, March 15, 1996 -- Immunex Corporation (Nasdaq: IMNX) announced today that it received marketing clearance from the U.S. Food and Drug Administration (FDA) for etoposide injection (also known as VP-16), a generic cancer chemotherapy agent indicated for the treatment of refractory testicular tumors and small cell lung cancer. "Etoposide advances our strategy of providing our customers with a broad range of oncology products -- including tools for the diagnosis, treatment, and supportive care in cancer treatment," said Michael Kranda, Immunex president and chief operating officer. Etoposide expands the spectrum of oncology products available from Immunex, which includes the Biomira Truquant(R) BR(TM) (a test for the detection of recurrent breast cancer), Novantrone(R) (mitoxantrone for injection concentrate), Thioplex(R) (thiotepa for injection), leucovorin calcium, methotrexate sodium, and Leukine(R) (sargramostim), a yeast-derived granulocyte-macrophage colony stimulating factor. Etoposide is a semi-synthetic derivative of a plant-derived toxin that inhibits the protein synthesis and DNA replication of tumor cells. The generic drug was co-developed by Immunexand Wyeth-Ayerst Research and is available in 100 and 250 milligram vials. The 250 milligram vial is available exclusively from Immunex. Immunexis a biopharmaceutical company dedicated to developing immune system science to protect human health. American Home Products Company (NYSE: AHP) owns a majority interest in Immunex. AHP is one of the world's largest research-based pharmaceutical and health care products companies and is a leading developer, manufacturer and marketer of prescription drugs and over-the-counter medications. It is also a leader in vaccines, generic pharmaceuticals, biotechnology, agricultural products, animal health care, medical devices and food products. --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.